Literature DB >> 12503315

Buffered non-fermenter system for lab-scale production of secreted recombinant His-tagged proteins in Saccharomyces cerevisiae.

Chatri Ngamkitidechakul1, Sally S Twining.   

Abstract

Expression of recombinant proteins using a secretion system can minimize co-purification of contaminating host proteins. Production of His-tagged recombinant proteins in the yeast alpha-factor secretion system has previously required a fermenter system to control the growth conditions such as pH of the yeast culture. We describe an inexpensive non-fermenter system for the production of secreted recombinant His-tagged proteins in Saccharomyces cerevisiae that uses a buffered low peptone YP glycerol medium, which does not interfere with immobilized metal affinity chromatography. Maspin, a tumor suppressor serpin, was expressed as a secreted N-terminal His/FLAG-tagged protein. Purification of the soluble active recombinant protein only requires centrifugation, concentration by ultrafiltration, and Ni2+ affinity chromatography. Purified protein yields of this system are 3-5 mg/L culture medium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12503315     DOI: 10.2144/02336pt02

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  7 in total

1.  Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts.

Authors:  Debra J Warejcka; Malathi Narayan; Sally S Twining
Journal:  Exp Eye Res       Date:  2011-07-27       Impact factor: 3.467

2.  High mobility group box 1 promotes endothelial cell angiogenic behavior in vitro and improves muscle perfusion in vivo in response to ischemic injury.

Authors:  Ulka Sachdev; Xiangdong Cui; Guiying Hong; Seung Namkoong; Jenny M Karlsson; Catherine J Baty; Edith Tzeng
Journal:  J Vasc Surg       Date:  2011-09-23       Impact factor: 4.268

3.  High mobility group Box 1 inhibits human pulmonary artery endothelial cell migration via a Toll-like receptor 4- and interferon response factor 3-dependent mechanism(s).

Authors:  Eileen M Bauer; Richard Shapiro; Timothy R Billiar; Philip M Bauer
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

4.  HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia.

Authors:  Ulka Sachdev; Xiangdong Cui; Edith Tzeng
Journal:  J Vasc Surg       Date:  2013-02-12       Impact factor: 4.268

5.  TLR4 Deters Perfusion Recovery and Upregulates Toll-like Receptor 2 (TLR2) in Ischemic Skeletal Muscle and Endothelial Cells.

Authors:  Jia Xu; Kelly Benabou; Xiangdong Cui; Marissa Madia; Edith Tzeng; Timothy Billiar; Simon Watkins; Ulka Sachdev
Journal:  Mol Med       Date:  2015-07-14       Impact factor: 6.354

6.  Chloroquine improves the response to ischemic muscle injury and increases HMGB1 after arterial ligation.

Authors:  Jun Xu; Xiangdong Cui; Jiehua Li; Panagiotis Koutakis; Iraklis Pipinos; Edith Tzeng; Alex Chen; Ulka Sachdev
Journal:  J Vasc Surg       Date:  2017-03-01       Impact factor: 4.268

7.  Extracellular high mobility group box-1 (HMGB1) inhibits enterocyte migration via activation of Toll-like receptor-4 and increased cell-matrix adhesiveness.

Authors:  Shipan Dai; Chhinder Sodhi; Selma Cetin; Ward Richardson; Maria Branca; Matthew D Neal; Thomas Prindle; Congrong Ma; Richard A Shapiro; Bin Li; James H-C Wang; David J Hackam
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.